$PFX
PhenixFIN Corp Stock $pfx

$pfx Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-K Financial Statement

#000121390023098182 Filed on December 22, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2023
Revenue	$1.709M	$5.678M	$6.510M
YoY Change	3.65%	11.43%	-58.12%
Cost Of Revenue	$1.542M	$1.502M	$5.532M
YoY Change	25.05%	24.88%	8.19%
Gross Profit	$4.180M	$4.176M	$14.60M
YoY Change	20.45%	7.28%	39.97%
Gross Profit Margin	244.58%	73.55%	224.27%
Selling, General & Admin	$2.471M	$2.308M	$8.090M
YoY Change	35.65%	14.29%	15.58%
% of Gross Profit	59.11%	55.26%	55.41%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization			$287.0K
YoY Change
% of Gross Profit			1.97%
Operating Expenses	$94.00K	$2.308M	$8.090M
YoY Change	-94.84%	14.29%	15.58%
Operating Profit	$4.086M	$1.868M	$6.510M
YoY Change	147.81%	-0.27%	89.72%
Interest Expense	$1.542M	$5.473M	$5.532M
YoY Change	28.18%	-183.86%	-159.86%
% of Operating Profit	37.74%	292.99%	84.97%
Other Income/Expense, Net	$200.0K		$700.0K
YoY Change	0.0%		0.0%
Pretax Income	$4.534M	$7.342M	$26.92M
YoY Change	14.72%	-257.77%	-540.78%
Income Tax
% Of Pretax Income
Net Earnings	$871.0K	$7.342M	$26.92M
YoY Change	-77.96%	-257.77%	-540.78%
Net Earnings / Revenue	50.97%	129.3%	413.48%
Basic Earnings Per Share	$2.19		$12.87
Diluted Earnings Per Share	$2.19	$3.53	$12.87
COMMON SHARES
Basic Shares Outstanding	2.073M shares	2.089M shares	2.092M shares
Diluted Shares Outstanding	2.073M shares		2.092M shares

Balance Sheet

Concept	2023 Q4	2023 Q3	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$12.17M	$5.988M	$5.988M
YoY Change	-31.04%	-73.7%	-73.7%
Cash & Equivalents	$12.20M	$6.000M	$5.988M
Short-Term Investments		$79.06M
Other Short-Term Assets	$132.3K	$199.0K	$199.0K
YoY Change	-65.6%	-59.31%	-59.31%
Inventory
Prepaid Expenses
Receivables	$1.400M	$4.911M	$4.911M
Other Receivables	$660.3K	$31.43K	$602.1K
Total Short-Term Assets	$14.37M	$11.70M	$11.70M
YoY Change	-30.67%	-52.58%	-52.58%
LONG-TERM ASSETS
Property, Plant & Equipment	$417.2K	$449.8K	$449.8K
YoY Change	-12.83%	-12.34%	-12.34%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$222.2M	$226.5M	$226.5M
YoY Change	21.25%	17.36%	17.36%
Other Assets	$615.6K	$833.0K	$699.1K
YoY Change	-41.62%	-30.16%
Total Long-Term Assets	$223.5M	$228.0M	$228.0M
YoY Change	21.02%	17.4%	17.4%
TOTAL ASSETS
Total Short-Term Assets	$14.37M	$11.70M	$11.70M
Total Long-Term Assets	$223.5M	$228.0M	$228.0M
Total Assets	$237.8M	$239.7M	$239.7M
YoY Change	15.81%	9.51%	9.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.615M	$7.190M	$7.190M
YoY Change	54.99%	-56.56%	252.4%
Accrued Expenses	$1.116M	$1.123M	$1.123M
YoY Change	7.5%	4.59%	4.59%
Deferred Revenue		$421.7K
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.804M	$8.313M	$8.313M
YoY Change	30.51%	160.68%	-53.03%
LONG-TERM LIABILITIES
Long-Term Debt	$84.34M	$84.25M	$84.25M
YoY Change	8.03%	8.07%	8.07%
Other Long-Term Liabilities	$0.00	$421.7K	$421.7K
YoY Change	-100.0%	28.62%	28.62%
Total Long-Term Liabilities	$84.34M	$84.67M	$84.67M
YoY Change	7.38%	8.15%	8.15%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.804M	$8.313M	$8.313M
Total Long-Term Liabilities	$84.34M	$84.67M	$84.67M
Total Liabilities	$87.14M	$92.99M	$92.99M
YoY Change	8.0%	-5.14%	-5.14%
SHAREHOLDERS EQUITY
Retained Earnings	-$543.6M	-$548.1M
YoY Change	-1.28%	-1.16%
Common Stock	$694.3M	$694.8M
YoY Change	2.81%	2.87%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$150.7M	$146.7M	$146.7M
YoY Change
Total Liabilities & Shareholders Equity	$237.8M	$239.7M	$239.7M
YoY Change	15.81%	9.51%	9.51%

Cashflow Statement

Concept	2023 Q4	2023 Q3	2023
OPERATING ACTIVITIES
Net Income	$871.0K	$7.342M	$26.92M
YoY Change	-77.96%	-257.77%	-540.78%
Depreciation, Depletion And Amortization			$287.0K
YoY Change
Cash From Operating Activities	$6.754M	-$4.506M	-$20.71M
YoY Change	-240.67%	-271.57%	-29.33%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$1.058M
YoY Change			-106.24%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$568.6K	-373.8K	$3.926M
YoY Change	81.93%	-91.19%	-122.61%
NET CHANGE
Cash From Operating Activities	$6.754M	-4.506M	-$20.71M
Cash From Investing Activities
Cash From Financing Activities	-$568.6K	-373.8K	$3.926M
Net Change In Cash	$6.186M	-4.880M	-$16.78M
YoY Change	-220.96%	202.21%	-64.04%
FREE CASH FLOW
Cash From Operating Activities	$6.754M	-$4.506M	-$20.71M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	1-35040
CY2023	dei	Entity Registrant Name EntityRegistrantName	PHENIXFIN CORPORATION
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	27-4576073
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	445 Park Avenue
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	10th Floor
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10022
CY2023	dei	City Area Code CityAreaCode	(212)
CY2023	dei	Local Phone Number LocalPhoneNumber	859-0390
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	false
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q1	dei	Entity Public Float EntityPublicFloat	60578642	usd
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	2072590	shares
CY2023	dei	Auditor Name AuditorName	KPMG LLP
CY2023	dei	Auditor Location AuditorLocation	New York, New York
CY2023Q3	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	226460691	usd
CY2022Q3	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	192956649	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5988223	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	22768066	usd
CY2023Q3	us-gaap	Interest Receivable InterestReceivable	971115	usd
CY2022Q3	us-gaap	Interest Receivable InterestReceivable	727576	usd
CY2022Q3	pfx	Paydown Receivable PaydownReceivable	112500	usd
CY2023Q3	us-gaap	Dividends Receivable DividendsReceivable	161479	usd
CY2022Q3	us-gaap	Dividends Receivable DividendsReceivable	269330	usd
CY2023Q3	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	31425	usd
CY2022Q3	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	36992	usd
CY2023Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	833000	usd
CY2022Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1192677	usd
CY2023Q3	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	699124	usd
CY2022Q3	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	50000	usd
CY2023Q3	pfx	Due From Affiliates Amount DueFromAffiliatesAmount	409214	usd
CY2022Q3	pfx	Due From Affiliates Amount DueFromAffiliatesAmount	271962	usd
CY2023Q3	pfx	Prepaid Share Repurchases PrepaidShareRepurchases	199019	usd
CY2022Q3	pfx	Prepaid Share Repurchases PrepaidShareRepurchases	489156	usd
CY2023Q3	us-gaap	Accounts Receivable Net AccountsReceivableNet	3940175	usd
CY2023Q3	us-gaap	Assets Assets	239693465	usd
CY2022Q3	us-gaap	Assets Assets	218874908	usd
CY2023Q3	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	1688835	usd
CY2022Q3	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	2059164	usd
CY2023Q3	us-gaap	Notes Payable NotesPayable	84253106	usd
CY2022Q3	us-gaap	Notes Payable NotesPayable	77962636	usd
CY2023Q3	pfx	Payable For Investments Purchased PayableForInvestmentsPurchased	4123059	usd
CY2022Q3	pfx	Payable For Investments Purchased PayableForInvestmentsPurchased	16550000	usd
CY2023Q3	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	3066984	usd
CY2022Q3	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	2040277	usd
CY2023Q3	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	690398	usd
CY2022Q3	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	503125	usd
CY2023Q3	us-gaap	Other Liabilities OtherLiabilities	432698	usd
CY2022Q3	us-gaap	Other Liabilities OtherLiabilities	572949	usd
CY2023Q3	us-gaap	Deferred Revenue DeferredRevenue	421685	usd
CY2022Q3	us-gaap	Deferred Revenue DeferredRevenue	325602	usd
CY2022Q3	pfx	Administrator Expenses Payable AdministratorExpensesPayable	74911	usd
CY2023Q3	us-gaap	Liabilities Liabilities	92987930	usd
CY2022Q3	us-gaap	Liabilities Liabilities	98029500	usd
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	5000000	shares
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	5000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2723709	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2723709	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2073713	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2102129	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	2074	usd
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	2102	usd
CY2023Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	694812239	usd
CY2022Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	675401802	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-548108778	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-554558496	usd
CY2023Q3	pfx	Total Net Assets TotalNetAssets	146705535	usd
CY2022Q3	pfx	Total Net Assets TotalNetAssets	120845408	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	239693465	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	218874908	usd
CY2023Q3	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	70.75
CY2022Q3	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	57.49
CY2023	pfx	Interest Income On Non Control And Non Affiliate Investments Cash InterestIncomeOnNonControlAndNonAffiliateInvestmentsCash	8031539	usd
CY2022	pfx	Interest Income On Non Control And Non Affiliate Investments Cash InterestIncomeOnNonControlAndNonAffiliateInvestmentsCash	5207850	usd
CY2021	pfx	Interest Income On Non Control And Non Affiliate Investments Cash InterestIncomeOnNonControlAndNonAffiliateInvestmentsCash	5974807	usd
CY2023	pfx	Payment In Kind Interest Income On Non Control And Non Affiliate Investments PaymentInKindInterestIncomeOnNonControlAndNonAffiliateInvestments	506555	usd
CY2022	pfx	Payment In Kind Interest Income On Non Control And Non Affiliate Investments PaymentInKindInterestIncomeOnNonControlAndNonAffiliateInvestments	444741	usd
CY2021	pfx	Payment In Kind Interest Income On Non Control And Non Affiliate Investments PaymentInKindInterestIncomeOnNonControlAndNonAffiliateInvestments	609964	usd
CY2023	pfx	Interest Income On Affiliate Investments Cash InterestIncomeOnAffiliateInvestmentsCash	1925293	usd
CY2022	pfx	Interest Income On Affiliate Investments Cash InterestIncomeOnAffiliateInvestmentsCash	639733	usd
CY2021	pfx	Interest Income On Affiliate Investments Cash InterestIncomeOnAffiliateInvestmentsCash	1099809	usd
CY2023	pfx	Payment In Kind Interest Income On Affiliate Investments PaymentInKindInterestIncomeOnAffiliateInvestments	460856	usd
CY2022	pfx	Payment In Kind Interest Income On Affiliate Investments PaymentInKindInterestIncomeOnAffiliateInvestments	374981	usd
CY2021	pfx	Payment In Kind Interest Income On Affiliate Investments PaymentInKindInterestIncomeOnAffiliateInvestments	327804	usd
CY2023	pfx	Interest Income On Controlled Investments Cash InterestIncomeOnControlledInvestmentsCash	667312	usd
CY2022	pfx	Interest Income On Controlled Investments Cash InterestIncomeOnControlledInvestmentsCash	2489381	usd
CY2021	pfx	Interest Income On Controlled Investments Cash InterestIncomeOnControlledInvestmentsCash	75000	usd
CY2023	pfx	Payment In Kind Interest Income On Controlled Investments PaymentInKindInterestIncomeOnControlledInvestments	557981	usd
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	12149536	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	9156686	usd
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	8087384	usd
CY2023	us-gaap	Investment Income Dividend InvestmentIncomeDividend	6856268	usd
CY2022	us-gaap	Investment Income Dividend InvestmentIncomeDividend	5503425	usd
CY2021	us-gaap	Investment Income Dividend InvestmentIncomeDividend	21564348	usd
CY2023	us-gaap	Interest Income Money Market Deposits InterestIncomeMoneyMarketDeposits	400031	usd
CY2022	us-gaap	Interest Income Money Market Deposits InterestIncomeMoneyMarketDeposits	139942	usd
CY2021	us-gaap	Interest Income Money Market Deposits InterestIncomeMoneyMarketDeposits	10402	usd
CY2023	us-gaap	Fee Income FeeIncome	324290	usd
CY2022	us-gaap	Fee Income FeeIncome	420279	usd
CY2021	us-gaap	Fee Income FeeIncome	2566519	usd
CY2023	us-gaap	Other Income OtherIncome	402138	usd
CY2022	us-gaap	Other Income OtherIncome	323828	usd
CY2021	us-gaap	Other Income OtherIncome	78204	usd
CY2023	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	20132263	usd
CY2022	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	15544160	usd
CY2021	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	32306857	usd
CY2021	us-gaap	Management Fee Expense ManagementFeeExpense	1146403	usd
CY2023	us-gaap	Interest And Debt Expense InterestAndDebtExpense	5531833	usd
CY2022	us-gaap	Interest And Debt Expense InterestAndDebtExpense	5113105	usd
CY2021	us-gaap	Interest And Debt Expense InterestAndDebtExpense	5800100	usd
CY2023	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	4186852	usd
CY2022	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	2952106	usd
CY2021	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	1993277	usd
CY2023	us-gaap	Professional Fees ProfessionalFees	1404676	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	1340828	usd
CY2021	us-gaap	Professional Fees ProfessionalFees	559975	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	983274	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1103125	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1012147	usd
CY2023	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	728833	usd
CY2022	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	712000	usd
CY2021	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	1039717	usd
CY2023	us-gaap	General Insurance Expense GeneralInsuranceExpense	466319	usd
CY2022	us-gaap	General Insurance Expense GeneralInsuranceExpense	590178	usd
CY2021	us-gaap	General Insurance Expense GeneralInsuranceExpense	1619536	usd
CY2023	pfx	Administrative Services Expense AdministrativeServicesExpense	320310	usd
CY2022	pfx	Administrative Services Expense AdministrativeServicesExpense	301281	usd
CY2021	pfx	Administrative Services Expense AdministrativeServicesExpense	612983	usd
CY2023	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	13622097	usd
CY2022	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	12112623	usd
CY2021	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	13784138	usd
CY2023	us-gaap	Net Investment Income NetInvestmentIncome	6510166	usd
CY2022	us-gaap	Net Investment Income NetInvestmentIncome	3431537	usd
CY2021	us-gaap	Net Investment Income NetInvestmentIncome	18522719	usd
CY2023	pfx	Realized Gain Lossfor Non Controlled Non Affiliated Investments RealizedGainLossforNonControlledNonAffiliatedInvestments	-10538228	usd
CY2022	pfx	Realized Gain Lossfor Non Controlled Non Affiliated Investments RealizedGainLossforNonControlledNonAffiliatedInvestments	810240	usd
CY2021	pfx	Realized Gain Lossfor Non Controlled Non Affiliated Investments RealizedGainLossforNonControlledNonAffiliatedInvestments	7747672	usd
CY2023	pfx	Realized Gain Loss From Affiliate Investments RealizedGainLossFromAffiliateInvestments	-1018267	usd
CY2022	pfx	Realized Gain Loss From Affiliate Investments RealizedGainLossFromAffiliateInvestments	4408961	usd
CY2021	pfx	Realized Gain Loss From Affiliate Investments RealizedGainLossFromAffiliateInvestments	-10088405	usd
CY2023	pfx	Realized Gain Loss From Control Investments RealizedGainLossFromControlInvestments	23456	usd
CY2022	pfx	Realized Gain Loss From Control Investments RealizedGainLossFromControlInvestments	1850	usd
CY2021	pfx	Realized Gain Loss From Control Investments RealizedGainLossFromControlInvestments	-40144795	usd
CY2023	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-11533039	usd
CY2022	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	5221051	usd
CY2021	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-42485528	usd
CY2023	pfx	Unrealized Appreciation Depreciation On Non Control And Non Affiliate Investments UnrealizedAppreciationDepreciationOnNonControlAndNonAffiliateInvestments	15954552	usd
CY2022	pfx	Unrealized Appreciation Depreciation On Non Control And Non Affiliate Investments UnrealizedAppreciationDepreciationOnNonControlAndNonAffiliateInvestments	-16701153	usd
CY2021	pfx	Unrealized Appreciation Depreciation On Non Control And Non Affiliate Investments UnrealizedAppreciationDepreciationOnNonControlAndNonAffiliateInvestments	-5022484	usd
CY2023	pfx	Unrealized Appreciation Depreciation On Affiliate Investments UnrealizedAppreciationDepreciationOnAffiliateInvestments	7327399	usd
CY2022	pfx	Unrealized Appreciation Depreciation On Affiliate Investments UnrealizedAppreciationDepreciationOnAffiliateInvestments	96490	usd
CY2021	pfx	Unrealized Appreciation Depreciation On Affiliate Investments UnrealizedAppreciationDepreciationOnAffiliateInvestments	-10342450	usd
CY2023	pfx	Unrealized Appreciation Depreciation On Control Investments UnrealizedAppreciationDepreciationOnControlInvestments	8659262	usd
CY2022	pfx	Unrealized Appreciation Depreciation On Control Investments UnrealizedAppreciationDepreciationOnControlInvestments	2141326	usd
CY2021	pfx	Unrealized Appreciation Depreciation On Control Investments UnrealizedAppreciationDepreciationOnControlInvestments	40728006	usd
CY2023	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	31941213	usd
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-14463337	usd
CY2021	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	25363072	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-296197	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-122355	usd
CY2023	pfx	Total Realized And Unrealized Gainslosses TotalRealizedAndUnrealizedGainslosses	20408174	usd
CY2022	pfx	Total Realized And Unrealized Gainslosses TotalRealizedAndUnrealizedGainslosses	-9538483	usd
CY2021	pfx	Total Realized And Unrealized Gainslosses TotalRealizedAndUnrealizedGainslosses	-17244811	usd
CY2023	pfx	Net Increase Decrease In Net Assets Resulting From Operations NetIncreaseDecreaseInNetAssetsResultingFromOperations	26918340	usd
CY2022	pfx	Net Increase Decrease In Net Assets Resulting From Operations NetIncreaseDecreaseInNetAssetsResultingFromOperations	-6106946	usd
CY2021	pfx	Net Increase Decrease In Net Assets Resulting From Operations NetIncreaseDecreaseInNetAssetsResultingFromOperations	1277908	usd
CY2023	pfx	Weighted Average Basic Earnings Per Share WeightedAverageBasicEarningsPerShare	12.87
CY2022	pfx	Weighted Average Basic Earnings Per Share WeightedAverageBasicEarningsPerShare	-2.63
CY2021	pfx	Weighted Average Basic Earnings Per Share WeightedAverageBasicEarningsPerShare	0.48
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2092326	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2323601	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2677891	shares
CY2020Q3	us-gaap	Assets Net AssetsNet	150619517	usd
CY2021	us-gaap	Net Investment Income NetInvestmentIncome	18522719	usd
CY2021	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-42485528	usd
CY2021	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	25363072	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-122355	usd
CY2021	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	8203444	usd
CY2021	pfx	Total Increase Decrease In Net Assets Value TotalIncreaseDecreaseInNetAssetsValue	-6925536	usd
CY2021Q3	us-gaap	Assets Net AssetsNet	143693981	usd
CY2022	us-gaap	Net Investment Income NetInvestmentIncome	3431537	usd
CY2022	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	5221051	usd
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-14463337	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-296197	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	265798	usd
CY2022	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	16475829	usd
CY2022	pfx	Total Increase Decrease In Net Assets Value TotalIncreaseDecreaseInNetAssetsValue	-22848573	usd
CY2022Q3	us-gaap	Assets Net AssetsNet	120845408	usd
CY2023	us-gaap	Net Investment Income NetInvestmentIncome	6510166	usd
CY2023	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-11533039	usd
CY2023	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	31941213	usd
CY2023	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	1058213	usd
CY2023	pfx	Total Increase Decrease In Net Assets Value TotalIncreaseDecreaseInNetAssetsValue	25860127	usd
CY2023Q3	us-gaap	Assets Net AssetsNet	146705535	usd
CY2023	pfx	Net Increasedecrease In Net Assets Resulting From Operations Amount NetIncreasedecreaseInNetAssetsResultingFromOperationsAmount	26918340	usd
CY2022	pfx	Net Increasedecrease In Net Assets Resulting From Operations Amount NetIncreasedecreaseInNetAssetsResultingFromOperationsAmount	-6106946	usd
CY2021	pfx	Net Increasedecrease In Net Assets Resulting From Operations Amount NetIncreasedecreaseInNetAssetsResultingFromOperationsAmount	1277908	usd
CY2023	us-gaap	Interest And Dividend Income Operating Paid In Kind InterestAndDividendIncomeOperatingPaidInKind	1525392	usd
CY2022	us-gaap	Interest And Dividend Income Operating Paid In Kind InterestAndDividendIncomeOperatingPaidInKind	819722	usd
CY2021	us-gaap	Interest And Dividend Income Operating Paid In Kind InterestAndDividendIncomeOperatingPaidInKind	937768	usd
CY2023	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	1560684	usd
CY2022	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	219513	usd
CY2021	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	44455	usd
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	370329	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	368471	usd
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	363812	usd
CY2023	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	286597	usd
CY2023	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-11533039	usd
CY2022	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	5221051	usd
CY2021	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-42485528	usd
CY2023	us-gaap	Increase Decrease In Trading Securities IncreaseDecreaseInTradingSecurities	31941213	usd
CY2022	us-gaap	Increase Decrease In Trading Securities IncreaseDecreaseInTradingSecurities	-14463337	usd
CY2021	us-gaap	Increase Decrease In Trading Securities IncreaseDecreaseInTradingSecurities	25363072	usd
CY2023	us-gaap	Proceeds From Disposition Of Investment Operating Activity ProceedsFromDispositionOfInvestmentOperatingActivity	66642920	usd
CY2022	us-gaap	Proceeds From Disposition Of Investment Operating Activity ProceedsFromDispositionOfInvestmentOperatingActivity	123801226	usd
CY2021	us-gaap	Proceeds From Disposition Of Investment Operating Activity ProceedsFromDispositionOfInvestmentOperatingActivity	124303888	usd
CY2023	us-gaap	Payments For Purchase Of Investment Operating Activity PaymentsForPurchaseOfInvestmentOperatingActivity	76652712	usd
CY2022	us-gaap	Payments For Purchase Of Investment Operating Activity PaymentsForPurchaseOfInvestmentOperatingActivity	173321143	usd
CY2021	us-gaap	Payments For Purchase Of Investment Operating Activity PaymentsForPurchaseOfInvestmentOperatingActivity	45340354	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-296197	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-122355	usd
CY2022	pfx	Increase Decreasein Fees Recivable IncreaseDecreaseinFeesRecivable	-1872700	usd
CY2021	pfx	Increase Decreasein Fees Recivable IncreaseDecreaseinFeesRecivable	1753672	usd
CY2023	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	243539	usd
CY2022	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	356000	usd
CY2021	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-252948	usd
CY2023	us-gaap	Increase Decrease Due From Affiliates IncreaseDecreaseDueFromAffiliates	137252	usd
CY2022	us-gaap	Increase Decrease Due From Affiliates IncreaseDecreaseDueFromAffiliates	271962	usd
CY2023	us-gaap	Increase Decrease In Receivable For Investment Sold IncreaseDecreaseInReceivableForInvestmentSold	3940175	usd
CY2023	us-gaap	Increase Decrease In Dividends Receivable IncreaseDecreaseInDividendsReceivable	-107851	usd
CY2022	us-gaap	Increase Decrease In Dividends Receivable IncreaseDecreaseInDividendsReceivable	188119	usd
CY2021	us-gaap	Increase Decrease In Dividends Receivable IncreaseDecreaseInDividendsReceivable	81211	usd
CY2023	pfx	Increase Decrease In Paydown Receivable IncreaseDecreaseInPaydownReceivable	-112500	usd
CY2022	pfx	Increase Decrease In Paydown Receivable IncreaseDecreaseInPaydownReceivable	-179515	usd
CY2021	pfx	Increase Decrease In Paydown Receivable IncreaseDecreaseInPaydownReceivable	292015	usd
CY2023	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-5567	usd
CY2022	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	36992	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-290137	usd
CY2023	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-359677	usd
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-159069	usd
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-691813	usd
CY2023	us-gaap	Increase Decrease In Payable For Investment Purchased IncreaseDecreaseInPayableForInvestmentPurchased	-12426941	usd
CY2022	us-gaap	Increase Decrease In Payable For Investment Purchased IncreaseDecreaseInPayableForInvestmentPurchased	14964000	usd
CY2021	us-gaap	Increase Decrease In Payable For Investment Purchased IncreaseDecreaseInPayableForInvestmentPurchased	1586000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1026707	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	623753	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-691701	usd
CY2022	us-gaap	Increase Decrease In Due To Affiliates IncreaseDecreaseInDueToAffiliates	-280323	usd
CY2021	us-gaap	Increase Decrease In Due To Affiliates IncreaseDecreaseInDueToAffiliates	227240	usd
CY2023	pfx	Increase Decreasein Administrator Expenses Payable IncreaseDecreaseinAdministratorExpensesPayable	74911	usd
CY2022	pfx	Increase Decreasein Administrator Expenses Payable IncreaseDecreaseinAdministratorExpensesPayable	-6991	usd
CY2021	pfx	Increase Decreasein Administrator Expenses Payable IncreaseDecreaseinAdministratorExpensesPayable	89045	usd
CY2023	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	187273	usd
CY2022	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	503125	usd
CY2021	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-801805	usd
CY2023	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	96083	usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	325602	usd
CY2021	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-10529	usd
CY2021	us-gaap	Increase Decrease In Management And Incentive Fees Payable IncreaseDecreaseInManagementAndIncentiveFeesPayable	-1392022	usd
CY2023	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-140251	usd
CY2022	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-40586	usd
CY2021	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	613534	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-20706050	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-29298371	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	95127377	usd
CY2023	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	36441941	usd
CY2022	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	57500000	usd
CY2023	us-gaap	Repayments Of Debt RepaymentsOfDebt	30521800	usd
CY2022	us-gaap	Repayments Of Debt RepaymentsOfDebt	55325000	usd
CY2021	us-gaap	Repayments Of Debt RepaymentsOfDebt	74012825	usd
CY2022	us-gaap	Payments Of Dividends PaymentsOfDividends	265798	usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	2311036	usd
CY2023	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	935721	usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1058213	usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	16964985	usd
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	8203444	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3926207	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-17366819	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-82216269	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-16779843	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-46665190	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	12911108	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	22768066	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	69433256	usd
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	56522148	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5988223	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	22768066	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	69433256	usd
CY2023	us-gaap	Interest Paid Capitalized InterestPaidCapitalized	4647166	usd
CY2022	us-gaap	Interest Paid Capitalized InterestPaidCapitalized	4241510	usd
CY2021	us-gaap	Interest Paid Capitalized InterestPaidCapitalized	6601905	usd
	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	41000000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Use of Estimates in the Preparation of Financial Statements</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p>
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6000000	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	22800000	usd
CY2023	us-gaap	Guarantees Indemnifications And Warranties Policies GuaranteesIndemnificationsAndWarrantiesPolicies	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Indemnification</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In the normal course of business, the Company enters into contractual agreements that provide general indemnifications against losses, costs, claims and liabilities arising from the performance of individual obligations under such agreements. The Company has had no material claims or payments pursuant to such agreements. The Company’s individual maximum exposure under these arrangements is unknown, as this would involve future claims that may be made against the Company that have not yet occurred. However, based on management’s experience, the Company expects the risk of loss to be remote.</span></p>
CY2023	us-gaap	Revenue Recognition Interest RevenueRecognitionInterest	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Revenue Recognition</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Interest income, adjusted for amortization of premium and accretion of discount, is recorded on an accrual basis. Discounts and premiums to par value on investments purchased are accreted and amortized into interest income over the life of the respective investment. Loan origination fees, original issue discount (“OID”) and market discounts or premiums are capitalized and amortized into interest income using the effective interest method or straight-line method, as applicable.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The Company holds debt investments in its portfolio that contain a payment-in-kind (“PIK”) interest provision. PIK interest, which represents contractually deferred interest added to the investment balance that is generally due at maturity, is recorded on the accrual basis to the extent such amounts are expected to be collected. PIK interest is not accrued if the Company does not expect the issuer to be able to pay all principal and interest when due. For the years ended September 30, 2023, 2022 and 2021, the Company earned approximately $1.5 million, $0.8 million, $0.9 million in PIK interest, respectively.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Amendment and transaction break-up fees associated with investments in portfolio companies are recognized as income when we become entitled to such fees. Prepayment penalties received by the Company for debt instruments paid back to the Company prior to the maturity date are recorded as income upon repayment of debt. Administrative agent fees received by the Company are capitalized as deferred revenue and recorded as fee income when the services are rendered. For the years ended September 30, 2023, 2022 and 2021, fee income was approximately $0.3 million, $0.4 million and $2.6 million, respectively (see Note 9).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Investment transactions are accounted for on a trade date basis. Realized gains or losses on investments are measured by the difference between the net proceeds from the disposition and the amortized cost basis of investment using the specific identification method, without regard to unrealized gains or losses previously recognized. No losses relating to restructuring transactions occurred during the years ended September 30, 2023, 2022 and 2021. The Company reports changes in fair value of investments as a component of the net unrealized appreciation/(depreciation) on investments in the Consolidated Statements of Operations.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Management reviews all loans that become 90 days or more past due on principal or interest or when there is reasonable doubt that principal or interest will be collected for possible placement on management’s designation of non-accrual status. Interest receivable is analyzed regularly and may be reserved against when deemed not collectible. Interest payments received on non-accrual loans may be recognized as income or applied to principal depending upon management’s judgment regarding collectability. Non-accrual loans are restored to accrual status when past due principal and interest is paid and, in management’s judgment, are likely to remain current, although we may make exceptions to this general rule if the loan has sufficient collateral value and is in the process of collection. At September 30, 2023, certain investments in four portfolio companies held by the Company were on non-accrual status with a combined fair value of approximately $6.5 million, or 2.9% of the fair value of our portfolio. At September 30, 2022, certain investments in five portfolio companies held by the Company were on non-accrual status with a combined fair value of approximately $5.2 million, or 2.7% of the fair value of our portfolio.</span></p>
CY2023	pfx	Payment In Kind Interest Income PaymentInKindInterestIncome	1500000	usd
CY2022	pfx	Payment In Kind Interest Income PaymentInKindInterestIncome	800000	usd
CY2021	pfx	Payment In Kind Interest Income PaymentInKindInterestIncome	900000	usd
CY2023Q3	pfx	Nonaccrual Investments At Fair Value NonaccrualInvestmentsAtFairValue	6500000	usd
CY2023	pfx	Portfolio Percentage At Fair Values PortfolioPercentageAtFairValues	0.029	pure
CY2022Q3	pfx	Nonaccrual Investments At Fair Value NonaccrualInvestmentsAtFairValue	5200000	usd
CY2022	pfx	Portfolio Percentage At Fair Values PortfolioPercentageAtFairValues	0.027	pure
CY2023	pfx	Percentage Of Investment Company Taxable Income PercentageOfInvestmentCompanyTaxableIncome	0.90	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.04	pure
CY2023	pfx	Distributable Ordinary Income Percentage DistributableOrdinaryIncomePercentage	0.98	pure
CY2023	pfx	Capital Gain Net Income Percentage CapitalGainNetIncomePercentage	0.982	pure
CY2023Q3	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	23100000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	26200000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	23100000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	26200000	usd
CY2023Q3	us-gaap	Excess Capital ExcessCapital	20468622	usd
CY2022Q3	us-gaap	Excess Capital ExcessCapital	3276372	usd
CY2021Q3	us-gaap	Excess Capital ExcessCapital	24688262	usd
CY2023Q3	us-gaap	Accumulated Deferred Investment Tax Credit AccumulatedDeferredInvestmentTaxCredit	20468622	usd
CY2022Q3	us-gaap	Accumulated Deferred Investment Tax Credit AccumulatedDeferredInvestmentTaxCredit	3276372	usd
CY2021Q3	us-gaap	Accumulated Deferred Investment Tax Credit AccumulatedDeferredInvestmentTaxCredit	19047396	usd
CY2021Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-5640866	usd
CY2021Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	115813000	usd
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	130290000	usd
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales	-112551000	usd
CY2022	pfx	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Realized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInRealizedGainLoss	12085000	usd
CY2022	pfx	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Changes In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangesInUnrealizedGainLoss	838000	usd
CY2022	us-gaap	Investment Company Distribution Ordinary Income InvestmentCompanyDistributionOrdinaryIncome	265798	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	265798	usd
CY2023Q3	us-gaap	Investments Investments	264100000	usd
CY2022Q3	us-gaap	Investments Investments	262600000	usd
CY2021Q3	us-gaap	Investments Investments	206900000	usd
CY2023	pfx	Undistributed Ordinary Income UndistributedOrdinaryIncome	2389267	usd
CY2021	pfx	Undistributed Ordinary Income UndistributedOrdinaryIncome	265798	usd
CY2023Q3	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	512809528	usd
CY2022Q3	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	485107934	usd
CY2021Q3	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	490032788	usd
CY2023	pfx	Other Temporary Differences OtherTemporaryDifferences	-57438	usd
CY2022	pfx	Other Temporary Differences OtherTemporaryDifferences	-73646	usd
CY2021	pfx	Other Temporary Differences OtherTemporaryDifferences	-89856	usd
CY2023Q3	us-gaap	Deferred Tax Liabilities Unrealized Gains On Trading Securities DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities	37631079	usd
CY2022Q3	us-gaap	Deferred Tax Liabilities Unrealized Gains On Trading Securities DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities	69376916	usd
CY2021Q3	us-gaap	Deferred Tax Liabilities Unrealized Gains On Trading Securities DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities	55318332	usd
CY2023Q3	us-gaap	Investment Company Distributable Earnings Loss Accumulated Ordinary Income Loss InvestmentCompanyDistributableEarningsLossAccumulatedOrdinaryIncomeLoss	548108778	usd
CY2022Q3	us-gaap	Investment Company Distributable Earnings Loss Accumulated Ordinary Income Loss InvestmentCompanyDistributableEarningsLossAccumulatedOrdinaryIncomeLoss	554558496	usd
CY2021Q3	us-gaap	Investment Company Distributable Earnings Loss Accumulated Ordinary Income Loss InvestmentCompanyDistributableEarningsLossAccumulatedOrdinaryIncomeLoss	545175178	usd
CY2023	pfx	Long Term Capital Loss LongTermCapitalLoss	509966576	usd
CY2023	pfx	Short Term Capital Loss ShortTermCapitalLoss	2842952	usd
CY2023	us-gaap	Investment Company Tax Return Of Capital Distribution InvestmentCompanyTaxReturnOfCapitalDistribution		usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>Company Investment Risk, Concentration of Credit Risk, and Liquidity Risk</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The Company has broad discretion in making investments. Investments generally consist of debt instruments that may be affected by business, financial market or legal uncertainties. Prices of investments may be volatile, and a variety of factors that are inherently difficult to predict, such as domestic or international economic and political developments, may significantly affect the results of the Company’s activities and the value of its investments. In addition, the value of the Company’s portfolio may fluctuate as the general level of interest rates fluctuate.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The value of the Company’s investments in loans may be detrimentally affected to the extent, among other things, that a borrower defaults on its obligations, there is insufficient collateral and/or there are extensive legal and other costs incurred in collecting on a defaulted loan, observable secondary or primary market yields for similar instruments issued by comparable companies increase materially or risk premiums required in the market between smaller companies, such as our borrowers, and those for which market yields are observable increase materially.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The Company’s assets may, at any time, include securities and other financial instruments or obligations that are illiquid or thinly traded, making purchase or sale of such securities and financial instruments at desired prices or in desired quantities difficult. Furthermore, the sale of any such investments may be possible only at substantial discounts, and it may be extremely difficult to value any such investments accurately.</span></p>
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	206500	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	62600	usd
CY2023Q3	us-gaap	Investment Owned Unrecognized Unrealized Appreciation Depreciation Net InvestmentOwnedUnrecognizedUnrealizedAppreciationDepreciationNet	143900	usd
CY2022Q3	us-gaap	Investment Owned Unrecognized Unrealized Appreciation Depreciation Net InvestmentOwnedUnrecognizedUnrealizedAppreciationDepreciationNet	299100	usd
CY2021Q3	us-gaap	Investment Owned Unrecognized Unrealized Appreciation Depreciation Net InvestmentOwnedUnrecognizedUnrealizedAppreciationDepreciationNet	981400	usd
CY2023Q3	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet	226461000	usd
CY2023Q3	pfx	Investment Owned Percentages Of Net Assets InvestmentOwnedPercentagesOfNetAssets	1	pure
CY2022Q3	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet	192957000	usd
CY2022Q3	pfx	Investment Owned Percentages Of Net Assets InvestmentOwnedPercentagesOfNetAssets	1	pure
CY2023Q3	us-gaap	Fair Value Hedges At Fair Value Net FairValueHedgesAtFairValueNet	226461000	usd
CY2023Q3	pfx	Investment Owned Percentage Of Net Assets InvestmentOwnedPercentageOfNetAssets	1	pure
CY2022Q3	us-gaap	Fair Value Hedges At Fair Value Net FairValueHedgesAtFairValueNet	192957000	usd
CY2022Q3	pfx	Investment Owned Percentage Of Net Assets InvestmentOwnedPercentageOfNetAssets	1	pure
CY2022Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	146675000	usd
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	53052000	usd
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales	-48851000	usd
CY2023	pfx	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Realized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInRealizedGainLoss	-9398000	usd
CY2023	pfx	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Changes In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangesInUnrealizedGainLoss	23838000	usd
CY2023Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	165316000	usd
CY2022	us-gaap	Investment Company Tax Return Of Capital Distribution InvestmentCompanyTaxReturnOfCapitalDistribution		usd
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet	200000	usd
CY2022Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	146675000	usd
CY2023	pfx	Net Change In Unrealized Gainloss NetChangeInUnrealizedGainloss	26500000	usd
CY2022	pfx	Net Change In Unrealized Gainloss NetChangeInUnrealizedGainloss	-2500000	usd
CY2023	pfx	Investment Transferred Inout Description InvestmentTransferredInoutDescription	Reclassifications impacting Level 3 of the fair value hierarchy are reported as transfers in/out of the Level 3 category as of the beginning of the quarter in which the reclassifications occur. During the year ended September 30, 2023, no investments were transferred in or out of Level 3. During the year ended September 30, 2022, $5,248 (in thousands) of investments were transferred out of Level 3 and $1,923 (in thousands) of investments were transferred into Level 3.
CY2017Q3	pfx	Membership Interest Percentage MembershipInterestPercentage	0.05	pure
CY2017Q3	us-gaap	Additional Collateral Aggregate Fair Value AdditionalCollateralAggregateFairValue	2400000	usd
CY2023Q3	pfx	Asset Coverage Percentage AssetCoveragePercentage	2	pure
CY2023	pfx	Asset Coverage Percentage With No Approval AssetCoveragePercentageWithNoApproval	2	pure
CY2023Q3	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	79058000	usd
CY2023Q3	pfx	Debt Instrument Outstanding Amount DebtInstrumentOutstandingAmount	85942000	usd
CY2023Q3	us-gaap	Notes Payable Current NotesPayableCurrent	84253000	usd
CY2023Q3	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	77547000	usd
CY2022Q3	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	80022000	usd
CY2022Q3	pfx	Debt Instrument Outstanding Amount DebtInstrumentOutstandingAmount	80022000	usd
CY2022Q3	us-gaap	Notes Payable Current NotesPayableCurrent	77963000	usd
CY2022Q3	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	72633000	usd
CY2022Q4	us-gaap	Line Of Credit Facility Expiration Period LineOfCreditFacilityExpirationPeriod	P3Y
CY2022Q4	us-gaap	Line Of Credit Assumed1 LineOfCreditAssumed1	50000000	usd
CY2023	us-gaap	Line Of Credit Facility Maximum Monthend Outstanding Amount LineOfCreditFacilityMaximumMonthendOutstandingAmount	28400000	usd
CY2022	us-gaap	Line Of Credit Facility Maximum Monthend Outstanding Amount LineOfCreditFacilityMaximumMonthendOutstandingAmount	0	usd
CY2023	us-gaap	Line Of Credit Facility Interest Rate During Period LineOfCreditFacilityInterestRateDuringPeriod	0.029	pure
CY2023	us-gaap	Line Of Credit Facility Commitment Fee Percentage LineOfCreditFacilityCommitmentFeePercentage	0.0025	pure
CY2023	us-gaap	Line Of Credit Facility Borrowing Capacity Description LineOfCreditFacilityBorrowingCapacityDescription	the Company borrowed $23.2 million under the Credit Facility and used these proceeds to redeem $22.6 million in aggregate principal amount of the issued and outstanding 2023 Notes, comprising all issued and outstanding 2023 Notes. The 2023 Notes were redeemed at 100% of their principal amount, plus accrued and unpaid interest thereon from September 30, 2022 through, but excluding January 17, 2023 (the “Redemption Date”).
CY2015Q4	us-gaap	Stock Issued1 StockIssued1	70800000	usd
CY2016Q1	pfx	Aggregate Principal Amount AggregatePrincipalAmount	3250000	usd
CY2020Q4	pfx	Aggregate Principal Amount AggregatePrincipalAmount	74012825	usd
CY2020Q4	pfx	Percentage Of Principal Amount PercentageOfPrincipalAmount	1	pure
CY2020Q4	pfx	Aggregate Principal Amount Per Share AggregatePrincipalAmountPerShare	25
CY2018Q4	pfx	Aggregate Principal Amount AggregatePrincipalAmount	12000000	usd
CY2018Q4	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	200000	usd
CY2022Q4	pfx	Aggregate Principal Amount AggregatePrincipalAmount	22521800	usd
CY2022Q4	pfx	Percentage Of Principal Amount PercentageOfPrincipalAmount	1	pure
CY2023	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	1390000	usd
CY2023	us-gaap	Debt Related Commitment Fees And Debt Issuance Costs DebtRelatedCommitmentFeesAndDebtIssuanceCosts	56000	usd
CY2023	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	287000	usd
CY2023	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	370000	usd
CY2022	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	368000	usd
CY2021	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	367000	usd
CY2023	us-gaap	Interest Expense InterestExpense	5532000	usd
CY2022	us-gaap	Interest Expense InterestExpense	5113000	usd
CY2021	us-gaap	Interest Expense InterestExpense	5800000	usd
CY2023	pfx	Debt Instrument Weighted Average Outstanding Balance DebtInstrumentWeightedAverageOutstandingBalance	81600000	usd
CY2022	pfx	Debt Instrument Weighted Average Outstanding Balance DebtInstrumentWeightedAverageOutstandingBalance	85398000	usd
CY2021	pfx	Debt Instrument Weighted Average Outstanding Balance DebtInstrumentWeightedAverageOutstandingBalance	82930000	usd
CY2020	pfx	Annual Rate Percentage AnnualRatePercentage	0.015	pure
CY2023	pfx	Annual Rate Percentage AnnualRatePercentage	0.00375	pure
CY2020Q4	pfx	Gross Assets GrossAssets	1000000000	usd
CY2021	pfx	Management Fees ManagementFees	1100000	usd
CY2023Q3	pfx	Deferred Compensation Arrangement With Individualcash Award Granted Amount DeferredCompensationArrangementWithIndividualcashAwardGrantedAmount	317000	usd
CY2022	pfx	Distributions Declaredinshares DistributionsDeclaredinshares	-0.12
CY2023	us-gaap	Proceeds From Fees Received ProceedsFromFeesReceived	0	usd
CY2022	us-gaap	Proceeds From Fees Received ProceedsFromFeesReceived	0	usd
CY2021	us-gaap	Proceeds From Fees Received ProceedsFromFeesReceived	2100000	usd
CY2023	pfx	Investment Company Unfunded Commitment InvestmentCompanyUnfundedCommitment	3375000	usd
CY2022	pfx	Investment Company Unfunded Commitment InvestmentCompanyUnfundedCommitment	6028000	usd
CY2023	us-gaap	Lessee Operating Lease Description LesseeOperatingLeaseDescription	The lease commenced September 1, 2021 and expires November 30, 2026.
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	141330	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	129552	usd
CY2021Q3	us-gaap	Security Deposit SecurityDeposit	72000	usd
CY2021Q3	us-gaap	Prepaid Rent PrepaidRent	12000	usd
CY2023Q3	us-gaap	Lessor Operating Lease Term Of Contract LessorOperatingLeaseTermOfContract	P3Y
CY2022Q3	us-gaap	Lessor Operating Lease Term Of Contract LessorOperatingLeaseTermOfContract	P4Y
CY2023Q3	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.0525	pure
CY2022Q3	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.0525	pure
CY2019	pfx	Distributions Declaredinshares DistributionsDeclaredinshares	-3
CY2022	pfx	Prepayment Fee Income PrepaymentFeeIncome	-235	usd
CY2023	pfx	Administrative Agent Fee Income AdministrativeAgentFeeIncome	-169	usd
CY2022	pfx	Administrative Agent Fee Income AdministrativeAgentFeeIncome	-94	usd
CY2021	pfx	Administrative Agent Fee Income AdministrativeAgentFeeIncome	-414	usd
CY2023	pfx	Amendment Fee Income AmendmentFeeIncome	53	usd
CY2022	pfx	Amendment Fee Income AmendmentFeeIncome	4	usd
CY2021	pfx	Amendment Fee Income AmendmentFeeIncome	94	usd
CY2023	pfx	Other Fees Income OtherFeesIncome	102	usd
CY2022	pfx	Other Fees Income OtherFeesIncome	87	usd
CY2021	pfx	Other Fees Income OtherFeesIncome	2059	usd
CY2023	pfx	Fee Income Total FeeIncomeTotal	324	usd
CY2022	pfx	Fee Income Total FeeIncomeTotal	420	usd
CY2021	pfx	Fee Income Total FeeIncomeTotal	2567	usd
CY2023	us-gaap	Other Expenses OtherExpenses	700000	usd
CY2022	us-gaap	Other Expenses OtherExpenses	700000	usd
CY2021	us-gaap	Other Expenses OtherExpenses	1000000	usd
CY2023	pfx	Investment Company Repurchases Of Commonstock InvestmentCompanyRepurchasesOfCommonstock	0.39
CY2022	pfx	Investment Company Repurchases Of Commonstock InvestmentCompanyRepurchasesOfCommonstock	3.16
CY2021	pfx	Investment Company Repurchases Of Commonstock InvestmentCompanyRepurchasesOfCommonstock	1.3
CY2023	us-gaap	Investment Company Net Asset Value Per Share Period Increase Decrease InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease	0.39
CY2022	us-gaap	Investment Company Net Asset Value Per Share Period Increase Decrease InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease	3.04
CY2021	us-gaap	Investment Company Net Asset Value Per Share Period Increase Decrease InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease	1.3
CY2019	us-gaap	Investment Company Net Asset Value Per Share Period Increase Decrease InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease	-3
CY2023	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	26918000	usd
CY2022	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-6107000	usd
CY2021	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	1278000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2092326	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2323601	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2677891	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	12.87
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.63
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.48
CY2022Q3	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	57.49
CY2021Q3	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	57.08
CY2020Q3	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	55.3
CY2019Q3	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	79.46
CY2018Q3	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	117.92
CY2023	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	3.11
CY2022	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	1.48
CY2021	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	6.92
CY2020	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	-1
CY2019	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	-7.66
CY2023	pfx	Realized Investment Gains Losses Per Share RealizedInvestmentGainsLossesPerShare	-5.51
CY2022	pfx	Realized Investment Gains Losses Per Share RealizedInvestmentGainsLossesPerShare	2.24
CY2021	pfx	Realized Investment Gains Losses Per Share RealizedInvestmentGainsLossesPerShare	-15.86
CY2020	pfx	Realized Investment Gains Losses Per Share RealizedInvestmentGainsLossesPerShare	-18.35
CY2019	pfx	Realized Investment Gains Losses Per Share RealizedInvestmentGainsLossesPerShare	-41.18
CY2023	pfx	Unrealized Investment Gains Losses Per Share UnrealizedInvestmentGainsLossesPerShare	15.27
CY2022	pfx	Unrealized Investment Gains Losses Per Share UnrealizedInvestmentGainsLossesPerShare	-6.22
CY2021	pfx	Unrealized Investment Gains Losses Per Share UnrealizedInvestmentGainsLossesPerShare	9.47
CY2020	pfx	Unrealized Investment Gains Losses Per Share UnrealizedInvestmentGainsLossesPerShare	-3.9
CY2019	pfx	Unrealized Investment Gains Losses Per Share UnrealizedInvestmentGainsLossesPerShare	14.13
CY2022	us-gaap	Extinguishment Of Debt Gain Loss Per Share Net Of Tax ExtinguishmentOfDebtGainLossPerShareNetOfTax	-0.13
CY2021	us-gaap	Extinguishment Of Debt Gain Loss Per Share Net Of Tax ExtinguishmentOfDebtGainLossPerShareNetOfTax	-0.05
CY2020	us-gaap	Extinguishment Of Debt Gain Loss Per Share Net Of Tax ExtinguishmentOfDebtGainLossPerShareNetOfTax	-0.91
CY2019	us-gaap	Extinguishment Of Debt Gain Loss Per Share Net Of Tax ExtinguishmentOfDebtGainLossPerShareNetOfTax	-0.75
CY2023	us-gaap	Investment Company Investment Income Loss From Operations Per Share InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare	12.87
CY2022	us-gaap	Investment Company Investment Income Loss From Operations Per Share InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare	-2.63
CY2021	us-gaap	Investment Company Investment Income Loss From Operations Per Share InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare	0.48
CY2020	us-gaap	Investment Company Investment Income Loss From Operations Per Share InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare	-24.16
CY2019	us-gaap	Investment Company Investment Income Loss From Operations Per Share InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare	-35.46
CY2023Q3	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	70.75
CY2022Q3	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	57.49
CY2021Q3	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	57.08
CY2020Q3	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	55.3
CY2019Q3	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	79.46
CY2023Q3	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	146705535	usd
CY2022Q3	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	120845408	usd
CY2021Q3	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	143693981	usd
CY2020Q3	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	150619517	usd
CY2019Q3	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	216432530	usd
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2073713	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2102129	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2517221	shares
CY2020Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2723709	shares
CY2019Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2723709	shares
CY2023Q3	us-gaap	Investment Company Market Value Per Share InvestmentCompanyMarketValuePerShare	37.9
CY2022Q3	us-gaap	Investment Company Market Value Per Share InvestmentCompanyMarketValuePerShare	34.88
CY2021Q3	us-gaap	Investment Company Market Value Per Share InvestmentCompanyMarketValuePerShare	42.9
CY2020Q3	us-gaap	Investment Company Market Value Per Share InvestmentCompanyMarketValuePerShare	17.83
CY2019Q3	us-gaap	Investment Company Market Value Per Share InvestmentCompanyMarketValuePerShare	51.8
CY2023	pfx	Investments Company Total Return Market Value InvestmentsCompanyTotalReturnMarketValue	0.0866	pure
CY2022	pfx	Investments Company Total Return Market Value InvestmentsCompanyTotalReturnMarketValue	-0.1869	pure
CY2021	pfx	Investments Company Total Return Market Value InvestmentsCompanyTotalReturnMarketValue	1.4061	pure
CY2020	pfx	Investments Company Total Return Market Value InvestmentsCompanyTotalReturnMarketValue	-0.6558	pure
CY2019	pfx	Investments Company Total Return Market Value InvestmentsCompanyTotalReturnMarketValue	-0.2991	pure
CY2020	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	-0.3041	pure
CY2019	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	-0.2947	pure
CY2023	pfx	Portfolio Turnover Rate PortfolioTurnoverRate	0.3262	pure
CY2022	pfx	Portfolio Turnover Rate PortfolioTurnoverRate	0.6943	pure
CY2021	pfx	Portfolio Turnover Rate PortfolioTurnoverRate	0.2497	pure
CY2020	pfx	Portfolio Turnover Rate PortfolioTurnoverRate	0.0566	pure
CY2019	pfx	Portfolio Turnover Rate PortfolioTurnoverRate	0.1193	pure
CY2023	us-gaap	Investment Company Investment Income Loss Ratio After Incentive Allocation InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation	0.048	pure
CY2022	us-gaap	Investment Company Investment Income Loss Ratio After Incentive Allocation InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation	0.0255	pure
CY2021	us-gaap	Investment Company Investment Income Loss Ratio After Incentive Allocation InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation	0.1244	pure
CY2020	us-gaap	Investment Company Investment Income Loss Ratio After Incentive Allocation InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation	-0.0164	pure
CY2019	us-gaap	Investment Company Investment Income Loss Ratio After Incentive Allocation InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation	-0.0796	pure
CY2023	us-gaap	Investment Company Expense Ratio After Incentive Allocation InvestmentCompanyExpenseRatioAfterIncentiveAllocation	0.1004	pure
CY2022	us-gaap	Investment Company Expense Ratio After Incentive Allocation InvestmentCompanyExpenseRatioAfterIncentiveAllocation	0.0902	pure
CY2021	us-gaap	Investment Company Expense Ratio After Incentive Allocation InvestmentCompanyExpenseRatioAfterIncentiveAllocation	0.0926	pure
CY2020	us-gaap	Investment Company Expense Ratio After Incentive Allocation InvestmentCompanyExpenseRatioAfterIncentiveAllocation	0.1464	pure
CY2019	us-gaap	Investment Company Expense Ratio After Incentive Allocation InvestmentCompanyExpenseRatioAfterIncentiveAllocation	0.2562	pure
CY2023	pfx	Investment Company Investment Income Percentage Of Nonrecurring Fee Income InvestmentCompanyInvestmentIncomePercentageOfNonrecurringFeeIncome	0.0161	pure
CY2022	pfx	Investment Company Investment Income Percentage Of Nonrecurring Fee Income InvestmentCompanyInvestmentIncomePercentageOfNonrecurringFeeIncome	0.027	pure
CY2021	pfx	Investment Company Investment Income Percentage Of Nonrecurring Fee Income InvestmentCompanyInvestmentIncomePercentageOfNonrecurringFeeIncome	0.0794	pure
CY2020	pfx	Investment Company Investment Income Percentage Of Nonrecurring Fee Income InvestmentCompanyInvestmentIncomePercentageOfNonrecurringFeeIncome	0.0233	pure
CY2019	pfx	Investment Company Investment Income Percentage Of Nonrecurring Fee Income InvestmentCompanyInvestmentIncomePercentageOfNonrecurringFeeIncome	0.0429	pure
CY2023	pfx	Average Debt Outstanding AverageDebtOutstanding	81599762	shares
CY2022	pfx	Average Debt Outstanding AverageDebtOutstanding	85397690	shares
CY2021	pfx	Average Debt Outstanding AverageDebtOutstanding	82930098	shares
CY2020	pfx	Average Debt Outstanding AverageDebtOutstanding	189038998	shares
CY2019	pfx	Average Debt Outstanding AverageDebtOutstanding	347991878	shares
CY2023	us-gaap	Basic Earnings Per Share Adjustment Pro Forma BasicEarningsPerShareAdjustmentProForma	39.18
CY2022	us-gaap	Basic Earnings Per Share Adjustment Pro Forma BasicEarningsPerShareAdjustmentProForma	36.75
CY2021	us-gaap	Basic Earnings Per Share Adjustment Pro Forma BasicEarningsPerShareAdjustmentProForma	30.97
CY2020	us-gaap	Basic Earnings Per Share Adjustment Pro Forma BasicEarningsPerShareAdjustmentProForma	69.4
CY2019	us-gaap	Basic Earnings Per Share Adjustment Pro Forma BasicEarningsPerShareAdjustmentProForma	127.76
CY2023	pfx	Asset Coverage Ratio Per Unit AssetCoverageRatioPerUnit	2707	usd
CY2022	pfx	Asset Coverage Ratio Per Unit AssetCoverageRatioPerUnit	2550	usd
CY2021	pfx	Asset Coverage Ratio Per Unit AssetCoverageRatioPerUnit	2856	usd
CY2020	pfx	Asset Coverage Ratio Per Unit AssetCoverageRatioPerUnit	1992	usd
CY2019	pfx	Asset Coverage Ratio Per Unit AssetCoverageRatioPerUnit	1842	usd
CY2023	pfx	Supplemental Data Credit Facility SupplementalDataCreditFacility	28441941	usd
CY2019	pfx	Supplemental Data Israeli Notes SupplementalDataIsraeliNotes	105136927	usd
CY2023	pfx	Weighted Average Common Stock Per Share WeightedAverageCommonStockPerShare	3.11
CY2022	pfx	Weighted Average Common Stock Per Share WeightedAverageCommonStockPerShare	1.48
CY2021	pfx	Weighted Average Common Stock Per Share WeightedAverageCommonStockPerShare	6.92
CY2020	pfx	Weighted Average Common Stock Per Share WeightedAverageCommonStockPerShare	-3.35
CY2019	pfx	Weighted Average Common Stock Per Share WeightedAverageCommonStockPerShare	-7.66
CY2023Q3	pfx	Asset Coverage Of Indebtedness AssetCoverageOfIndebtedness	1000	usd
CY2023Q3	us-gaap	Investment Company Senior Security Stock Asset Coverage Ratio InvestmentCompanySeniorSecurityStockAssetCoverageRatio	2.707	pure
CY2023Q3	us-gaap	Investment Company Senior Security Indebtedness Asset Coverage Ratio InvestmentCompanySeniorSecurityIndebtednessAssetCoverageRatio	2	pure
CY2022	us-gaap	Payments Of Capital Distribution PaymentsOfCapitalDistribution	265798	usd
CY2023Q3	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	649996	shares
CY2023Q3	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	25700000	usd
CY2023Q3	pfx	Percentage Of Shares Outstanding PercentageOfSharesOutstanding	0.239	pure
CY2023Q3	us-gaap	Debt Instrument Repurchase Amount DebtInstrumentRepurchaseAmount	9300000	usd
CY2023	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	39.6
CY2023	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	649996	shares
CY2023	pfx	Stock Repurchased And Retired During Period Values StockRepurchasedAndRetiredDuringPeriodValues	25737486	usd
CY2023	pfx	Stock Transferred To Treasury Stock StockTransferredToTreasuryStock	28291	shares
CY2023Q3	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	300	shares
CY2023	us-gaap	Investment Company Distribution Long Term Capital Gain InvestmentCompanyDistributionLongTermCapitalGain		usd
CY2022	us-gaap	Investment Company Distribution Long Term Capital Gain InvestmentCompanyDistributionLongTermCapitalGain		usd
CY2021	us-gaap	Investment Company Distribution Long Term Capital Gain InvestmentCompanyDistributionLongTermCapitalGain		usd
CY2023	dei	Auditor Firm AuditorFirmId	185
CY2023Q3	pfx	Paydown Receivable PaydownReceivable		usd
CY2023Q3	pfx	Administrator Expenses Payable AdministratorExpensesPayable		usd
CY2022	pfx	Payment In Kind Interest Income On Controlled Investments PaymentInKindInterestIncomeOnControlledInvestments		usd
CY2023	us-gaap	Management Fee Expense ManagementFeeExpense		usd
CY2022	us-gaap	Management Fee Expense ManagementFeeExpense		usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2023	pfx	Weighted Average Diluted Earnings Per Share WeightedAverageDilutedEarningsPerShare	12.87
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2677891	shares
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues		usd
CY2021	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther		usd
CY2022	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther		usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2023	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther		usd
CY2022	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges		usd
CY2021	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges		usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2023	pfx	Increase Decreasein Fees Recivable IncreaseDecreaseinFeesRecivable		usd
CY2021	us-gaap	Increase Decrease Due From Affiliates IncreaseDecreaseDueFromAffiliates		usd
CY2022	us-gaap	Increase Decrease In Receivable For Investment Sold IncreaseDecreaseInReceivableForInvestmentSold		usd
CY2021	us-gaap	Increase Decrease In Receivable For Investment Sold IncreaseDecreaseInReceivableForInvestmentSold		usd
CY2021	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables		usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense		usd
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense		usd
CY2023	us-gaap	Increase Decrease In Due To Affiliates IncreaseDecreaseInDueToAffiliates		usd
CY2023	us-gaap	Increase Decrease In Management And Incentive Fees Payable IncreaseDecreaseInManagementAndIncentiveFeesPayable		usd
CY2022	us-gaap	Increase Decrease In Management And Incentive Fees Payable IncreaseDecreaseInManagementAndIncentiveFeesPayable		usd
CY2021	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt		usd
CY2023	us-gaap	Payments Of Dividends PaymentsOfDividends		usd
CY2021	us-gaap	Payments Of Dividends PaymentsOfDividends		usd
CY2023	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		usd
CY2021	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		usd
CY2022	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts		usd
CY2021	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts		usd
CY2023Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax		usd
CY2022Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax		usd
CY2023	us-gaap	Investment Company Distribution Ordinary Income InvestmentCompanyDistributionOrdinaryIncome		usd
CY2021	us-gaap	Investment Company Distribution Ordinary Income InvestmentCompanyDistributionOrdinaryIncome		usd
CY2021	us-gaap	Investment Company Tax Return Of Capital Distribution InvestmentCompanyTaxReturnOfCapitalDistribution		usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate		usd
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate		usd
CY2022	pfx	Undistributed Ordinary Income UndistributedOrdinaryIncome		usd
CY2021Q3	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue		usd
CY2022	pfx	Investment Of Transfers In Out Of Affiliates InvestmentOfTransfersInOutOfAffiliates		usd
CY2022	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives		usd
CY2022	us-gaap	Debt Securities Realized Gain Loss DebtSecuritiesRealizedGainLoss		usd
CY2022Q3	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue		usd
CY2022	us-gaap	Investment Income Net InvestmentIncomeNet		usd
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet		usd
CY2022	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings		usd
CY2021	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings		usd
CY2022	us-gaap	Debt Related Commitment Fees And Debt Issuance Costs DebtRelatedCommitmentFeesAndDebtIssuanceCosts		usd
CY2021	us-gaap	Debt Related Commitment Fees And Debt Issuance Costs DebtRelatedCommitmentFeesAndDebtIssuanceCosts		usd
CY2022	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts		usd
CY2021	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts		usd
CY2023	pfx	Prepayment Fee Income PrepaymentFeeIncome		usd
CY2021	pfx	Prepayment Fee Income PrepaymentFeeIncome		usd
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2092326	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2323601	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2677891	shares
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	12.87
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.48
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.63
CY2023	us-gaap	Extinguishment Of Debt Gain Loss Per Share Net Of Tax ExtinguishmentOfDebtGainLossPerShareNetOfTax
CY2023	pfx	Distributions Declaredinshares DistributionsDeclaredinshares
CY2021	pfx	Distributions Declaredinshares DistributionsDeclaredinshares
CY2020	pfx	Distributions Declaredinshares DistributionsDeclaredinshares
CY2020	pfx	Investment Company Repurchases Of Commonstock InvestmentCompanyRepurchasesOfCommonstock
CY2019	pfx	Investment Company Repurchases Of Commonstock InvestmentCompanyRepurchasesOfCommonstock
CY2020	us-gaap	Investment Company Net Asset Value Per Share Period Increase Decrease InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease
CY2023	pfx	Supplemental Data Israeli Notes SupplementalDataIsraeliNotes		usd
CY2022	pfx	Supplemental Data Israeli Notes SupplementalDataIsraeliNotes		usd
CY2021	pfx	Supplemental Data Israeli Notes SupplementalDataIsraeliNotes		usd
CY2020	pfx	Supplemental Data Israeli Notes SupplementalDataIsraeliNotes		usd
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001490349

Files In Submission

Name	View Source	Status
0001213900-23-098182-index-headers.html	Edgar Link	pending
0001213900-23-098182-index.html	Edgar Link	pending
0001213900-23-098182.txt	Edgar Link	pending
0001213900-23-098182-xbrl.zip	Edgar Link	pending
ex99-2_001.jpg	Edgar Link	pending
f10k2023ex31-1_phenixfin.htm	Edgar Link	pending
f10k2023ex31-2_phenixfin.htm	Edgar Link	pending
f10k2023ex32-1_phenixfin.htm	Edgar Link	pending
f10k2023ex99-2_phenixfin.htm	Edgar Link	pending
f10k2023ex99-3_phenixfin.htm	Edgar Link	pending
f10k2023_phenixfincorp.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pfx-20230930.xsd	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
pfx-20230930_def.xml	Edgar Link	unprocessable
pfx-20230930_cal.xml	Edgar Link	unprocessable
f10k2023_phenixfincorp_htm.xml	Edgar Link	completed
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
pfx-20230930_lab.xml	Edgar Link	unprocessable
pfx-20230930_pre.xml	Edgar Link	unprocessable
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PFX
PhenixFIN Corp Stock $pfx

2023 Q4 Form 10-K Financial Statement

#000121390023098182 Filed on December 22, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PFX PhenixFIN Corp Stock $pfx

2023 Q4 Form 10-K Financial Statement

#000121390023098182 Filed on December 22, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PFX
PhenixFIN Corp Stock $pfx